Common Contracts

4 similar Underwriting Agreement contracts by BridgeBio Pharma, Inc., ESAB Corp, PTC Inc., Vertex, Inc.

PTC Inc. 5,830,905 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • August 7th, 2023 • PTC Inc. • Services-prepackaged software

The stockholder named in Schedule II hereto (the “Selling Stockholder”) of PTC Inc., a Massachusetts corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 5,830,905 shares (the “Securities”) of common stock, par value $0.01 per share (“Stock”) of the Company. To the extent that there is not more than one Underwriter named in Schedule I, the term “Underwriters” shall mean either the singular or plural as the context requires and the terms “each Underwriter” and “several Underwriters” shall mean the sole underwriter.

AutoNDA by SimpleDocs
Vertex, Inc. Class A Common Stock, par value $0.001 per share Underwriting Agreement
Underwriting Agreement • November 22nd, 2022 • Vertex, Inc. • Services-prepackaged software

The 2009 Jeffrey R. Westphal Generation‐Skipping Trust (the “Selling Stockholder”) proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to sell to Goldman Sachs & Co. LLC (the “Underwriter”) an aggregate of 1,500,000 shares (the “Shares”) of Class A common stock, par value $0.001 per share (the “Class A Stock” and, together with the Class B common stock, par value $0.001 per share, of Vertex, Inc., a Delaware corporation (the “Company”), collectively, the “Stock”) of the Company.

ESAB Corporation Common Stock, par value $0.001 per share Underwriting Agreement
Underwriting Agreement • November 18th, 2022 • ESAB Corp • General industrial machinery & equipment, nec • New York

The stockholder named in Schedule II hereto (the “Selling Stockholder”) of ESAB Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 6,003,431 shares (the “Shares”) of Common Stock, par value $0.001 per share (“Stock”) of the Company.

BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share Underwriting Agreement
Underwriting Agreement • February 17th, 2021 • BridgeBio Pharma, Inc. • Pharmaceutical preparations • New York

The stockholder named in Schedule II hereto (the “Selling Stockholder”) of BridgeBio Pharma, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 3,000,000 shares (the “Firm Securities”) and, at the election of the Underwriters, up to 450,000 additional shares (the “Optional Securities”) of Common Stock, par value $0.001 per share (“Stock”) of the Company by the Selling Stockholder (the Firm Securities and the Optional Securities that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Securities”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!